Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;34:442-449

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Touyz, R. M.
Right arrow Articles by Schiffrin, E. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Touyz, R. M.
Right arrow Articles by Schiffrin, E. L.
Related Collections
Right arrow Animal models of human disease
Right arrow Cell signalling/signal transduction
Right arrow Hypertension - basic studies
Right arrow Smooth muscle proliferation and differentiation

(Hypertension. 1999;34:442-449.)
© 1999 American Heart Association, Inc.


Scientific Contributions

Activation of the Na+-H+ Exchanger Modulates Angiotensin II–Stimulated Na+-Dependent Mg2+ Transport in Vascular Smooth Muscle Cells in Genetic Hypertension

Rhian M. Touyz; Ernesto L. Schiffrin

From the Multidisciplinary Research Group on Hypertension, Clinical Research Institute of Montreal, University of Montreal, Quebec, Canada.

Correspondence to R.M. Touyz, MD, PhD, Clinical Research Institute of Montreal, 110 Pine Ave W, Montreal, Quebec, H2W1R7 Canada. E-mail touyzr{at}ircm.qc.ca

Abstract—This study investigated the role of the Na+-H+ exchanger (NHE) on angiotensin II (Ang II)–induced activation of Na+-dependent Mg2+ transport in vascular smooth muscle cells (VSMCs) from Wistar-Kyoto rats (WKY; n=20) and spontaneously hypertensive rats (SHR; n=20). Intracellular free concentrations of Mg2+ ([Mg2+]i) and Na+ ([Na+]i) and intracellular pH (pHi) were measured with the specific fluorescent probes mag–fura 2-AM, SBFI-AM, and BCECF-AM, respectively. Na+ dependency of Mg2+ transport was assessed in Na+-free buffer, and the role of the NHE was determined with the highly selective NHE blocker 5-(N-methyl-N-isobutyl) amiloride (MIA). Basal [Mg2+]i was lower in SHR than WKY (0.59±0.01 versus 0.71±0.01 mmol/L, P<0.05). Basal pHi and [Na+]i were not different between the 2 groups. Ang II dose dependently increased [Na+]i and pHi and decreased [Mg2+]i. Responses were significantly greater (P<0.05) in SHR versus WKY ([Na+]i Emax=37.5±1.1 versus 33.7±1.9 mmol/L; pHi Emax=7.35±0.04 versus 7.20±0.01; [Mg2+]i Emin=0.28±0.09 versus 0.53±0.02 mmol/L, SHR versus WKY). In Na+-free buffer, Ang II–elicited [Mg2+]i responses were inhibited. MIA (1 µmol/L) inhibited Ang II–stimulated responses in WKY and normalized responses in SHR ([Mg2+]i Emin=0.49±0.02). Ang II–stimulated activation of NHE was significantly increased (P<0.05) in SHR (0.07±0.002 {Delta}pHi/s) compared with WKY (0.05±0.004 {Delta}pHi/s). These data demonstrate that in VSMCs [Mg2+]i regulation is Na+ dependent, that activation of NHE modulates Na+-Mg2+ transport, and that increased activity of NHE may play a role in altered Na+-dependent regulation of [Mg2+]i in SHR.


Key Words: Na+ • pH • signal transduction • vascular resistance • vasoconstriction • magnesium • rats, SHR




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. M. Touyz
Transient receptor potential melastatin 6 and 7 channels, magnesium transport, and vascular biology: implications in hypertension
Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1103 - H1118.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Y. He, G. Yao, C. Savoia, and R. M. Touyz
Transient Receptor Potential Melastatin 7 Ion Channels Regulate Magnesium Homeostasis in Vascular Smooth Muscle Cells: Role of Angiotensin II
Circ. Res., February 4, 2005; 96(2): 207 - 215.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. R. Isenovic, D. B. Jacobs, M. H. Kedees, Q. Sha, N. Milivojevic, K. Kawakami, G. Gick, and J. R. Sowers
Angiotensin II Regulation of the Na+ Pump Involves the Phosphatidylinositol-3 Kinase and p42/44 Mitogen-Activated Protein Kinase Signaling Pathways in Vascular Smooth Muscle Cells
Endocrinology, March 1, 2004; 145(3): 1151 - 1160.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
R. M. Touyz and E. L. Schiffrin
Signal Transduction Mechanisms Mediating the Physiological and Pathophysiological Actions of Angiotensin II in Vascular Smooth Muscle Cells
Pharmacol. Rev., December 1, 2000; 52(4): 639 - 672.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. M. Touyz, C. Mercure, and T. L. Reudelhuber
Angiotensin II Type I Receptor Modulates Intracellular Free Mg2+ in Renally Derived Cells via Na+-dependent Ca2+-independent Mechanisms
J. Biol. Chem., April 20, 2001; 276(17): 13657 - 13663.
[Abstract] [Full Text] [PDF]